• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Alvotech

< Previous 1 2 3 4 5 Next >
News headline image
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg
January 29, 2026
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech announces planned CEO succession and leadership transition
January 06, 2026
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Secures Term Loan Facility of USD 100 Million
December 31, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma
December 22, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
November 24, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
November 20, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
November 12, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea® (aflibercept)
November 10, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
November 06, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update
November 04, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05
November 02, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Changes in Global Business Development and Commercial Operations Team
October 22, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
October 06, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®
September 22, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech’s Proposed Biosimilar to Simponi® (golimumab) with Advanz Pharma as Commercialization Partner
September 22, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
September 19, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
September 04, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
August 21, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
August 13, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT
August 06, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
July 10, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland
July 09, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
July 01, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility
June 26, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Main Results of 2025 Annual and Extraordinary General Meeting
June 25, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
June 25, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)
June 23, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors
June 11, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
June 06, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)
June 05, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO RDY
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap